Interleukin-22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma
Oliver Waidmann1, Bernd Kronenberger, Patrick Scheiermann
1Medizinische Klinik 1, Schwerpunkt Gastroenterologie und Hepatologie, Klinikum der Goethe-Universität Frankfurt, Frankfurt/Main, Germany.
Hepatology (Baltimore, Md.)
|June 5, 2013
Abstract
No abstract available in PubMed .
